marketscan ccae drug (Truven Health)
90
Structured Review
Truven Health
marketscan ccae drug
Marketscan Ccae Drug, supplied by Truven Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/marketscan+ccae+drug/marketscan+ccae+drug/pmc06324274__jamanetwopen___1___e181755___s001-223-24-19
Average 90 stars, based on 1 article reviews
Marketscan Ccae Drug, supplied by Truven Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/marketscan+ccae+drug/marketscan+ccae+drug/pmc06324274__jamanetwopen___1___e181755___s001-223-24-19
Average 90 stars, based on 1 article reviews
marketscan ccae drug - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Standard Deviation:Article Title: Association of Hemoglobin A 1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin Article Snippet: Mean, Median and Standard Deviation of HbA1c Values for the Comparison of Sulfonylureas vs Thiazolidinediones Across Eight Study Sites Truven MarketScan CCAE Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 8.96 (1.84) 9.09 (1.73) 7.85 (1.91) 7.82 (1.86) Thiazolidinediones 8.97 (1.74) 9.13 (1.73) 7.76 (1.82) 7.76 (1.83) Columbia University Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 10.00 (2.3) 10.02 (2.51) 8.45 (1.92) 8.50 (1.96) Thiazolidinediones 9.94 (2.37) 9.23 (1.62) 8.36 (2.05) 8.36 (2.05) IQVIA Disease Analyser France Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 8.82 (3.14) 8.65 (1.44) 7.71 (11.49) 7.62 (2.33) Comparison:Article Title: Association of Hemoglobin A 1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin Article Snippet: Mean, Median and Standard Deviation of HbA1c Values for the Comparison of Sulfonylureas vs Thiazolidinediones Across Eight Study Sites Truven MarketScan CCAE Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 8.96 (1.84) 9.09 (1.73) 7.85 (1.91) 7.82 (1.86) Thiazolidinediones 8.97 (1.74) 9.13 (1.73) 7.76 (1.82) 7.76 (1.83) Columbia University Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 10.00 (2.3) 10.02 (2.51) 8.45 (1.92) 8.50 (1.96) Thiazolidinediones 9.94 (2.37) 9.23 (1.62) 8.36 (2.05) 8.36 (2.05) IQVIA Disease Analyser France Drug Before Index date After Index date Unmatched Matched Unmatched Matched AVG (SD) AVG (SD) AVG (SD) AVG (SD) Sulfonylureas 8.82 (3.14) 8.65 (1.44) 7.71 (11.49) 7.62 (2.33) |